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Abstract 
In the past, obtaining accurate medical diagnoses often necessitated surgery, 
required expensive diagnostic tests, or was completely unattainable. Additionally, the 
treatments of many medical conditions demanded highly invasive procedures that were 
frequently ineffective and unsuccessful. With modern developments in Positron Emission 
Tomography (PET), however, the medical world is becoming revolutionized. 
My involvement in PET innovations focused mainly on the development of a new PET 
scanner at CTI PET Systems, Inc., located in Knoxville, TN. This scanner is original due to 
its ability to provide greater image resolution, less scanning time, and automated source 
strength correction. The three major areas of my work included the Coincidence Point 
Source Interface, the Smart Source Board, and the Smart Source Testware. 
My greatest learning experience and most significant contribution to CTI's new PET 
scanner was the Smart Source Testware development. This task required me to write 
programs in Microsoft Visual C++, a language I had never used prior to this project. I also 
learned to read and write EEPROMs for the first time. The Smart Source Testware can be 
used for other applications in CTI PET scanners as well. My code is well documented and 
can easily be modified for use in new aSSignments with similar requirements. 
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2 Introduction 
During the summer of 2001, I worked as an engineering intern at CTI PET Systems, 
Inc. My main tasks involved electrical and computer design work for a new Positron 
Emission Tomography (PET) prototype. Since my academic major and interests are 
within the field of Nuclear Engineering (concentrated in Radiological Engineering), I 
wanted to continue this type of work for my Senior Honors Project. This project was 
supervised by engineers and management at CTI PET Systems, Inc. and by Dr. 
Harold L. Dodds. 
3 Positron Emission Tomography 
In the past, obtaining accurate medical diagnoses often necessitated surgery, 
required expensive diagnostic tests, or was completely unattainable. Additionally, the 
treatments of many medical conditions demanded highly invasive procedures that 
were frequently ineffective and unsuccessful. With modern developments in Positron 
Emission Tomography (PET), however, the medical world is becoming revolutionized. 
3.1 What is PET? 
PET is an emerging non-invasive, diagnostic imaging technique used for measuring 
the metabolic activity of cells in the human body. It is approved by many insurance 
carriers and used by physicians to diagnose and manage patient treatment plans for 
numerous diseases. 
Traditional diagnostic techniques, such as x-rays, computed tomography (CT) scans, 
or magnetic resonance imaging (MRI), produce images of the body's anatomy or 
structure. The premise with traditional techniques is that disease causes a change in 
structure or anatomy that can be observed. PET is unique because it produces 
images of the body's basic biochemistry. These biochemical processes may be 
altered by disease before there is a change in anatomy. For example, even in 
diseases such as Alzheimer's, where there is initially no gross structural abnormality, 
PET is able to show a biochemical change. 
In addition to imaging and measuring metabolic processes, there are other reasons 
that PET is a vital addition to the clinician's diagnostic toolbox. PET can validate 
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and/or modify patient management and care. Furthermore, it reduces patient risk and 
improves patient outcome. Lastly, PET decreases overall healthcare costs and 
defines appropriate pathways of medical care. 
3.2 PET Applications 
PET's uniqueness and value lie in its ability to quantitatively measure biochemical, 
metabolic, and functional activity in well defined, localized regions of the body. PET 
is primarily used in cardiology, neurology, and oncology. Specifically, it can be 
utilized to access the benefit of coronary artery bypass surgery, identify causes of 
childhood seizures and adult dementia, and detect and classify tumors (CTI PET 
Systems Patients' Info). 
3.2.1 Cardiology 
PET has several promising clinical applications among patients with known or 
suspected heart ailments. PET allows physicians to screen for coronary artery 
disease and to assess flow rates and flow reserve. It has also proven useful in 
distinguishing viable from nonviable myocardium tissue - knowledge which can be 
used to predict the therapeutic success of a cardiology patient after undergoing 
bypass, angioplasty, or transplant procedures. 
3.2.2 Neurology 
PET provides information for evaluating numerous neurological diseases such as 
Alzheimer's and other dementias, Parkinson's, Huntington's, and Down's Syndrome. 
Additionally, it offers assistance to epilepsy patients by localizing epileptic foci in order 
to qualify and identify the site for surgical intervention. It also enables the 
characterization, grading, and assessment of possible brain tumor recurrence. 
3.2.3 Oncology 
PET is the only modality that can accurately image many organs of the body with a 
single pass to allow discrimination between benign and malignant tissues. It can also 
provide information to determine whether a primary cancer has metastasized to other 
parts of the body. PET has demonstrated its usefulness in the early detection of 
recurrent tumors, grading of existing tumors, and the selection and evaluation of 
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therapy treatments. PET offers further assistance in the following ways: providing 
whole-body metastatic surveys, avoiding biopsies for low grade tumors, differentiating 
tumors from radiation necrosis non-invasively, determining the need for early change 
in course of ineffective chemotherapy, and avoiding unnecessary diagnostic and 
therapeutic surgeries. PET has proven a high degree of accuracy for determining the 
presence or spread of many malignant tumors including: lung cancer, ovarian cancer, 
breast cancer, lymphomas, head/neck tumors, colorectal cancer, melanoma, brain 
tumors, and pancreatic cancer . 
• 
• 
Mol. body PET scan 01 patiflllt 
with nult.static disease 
Figure 3.2. PET Image Used in Oncology 
3.3 How Does PET Work? 
The PET scan is a simple procedure involving the use of a small amount of a short 
half-lived radiopharmaceutical (produced by a cyclotron or generator), comparable to 
the amount used in other nuclear medicine procedures. A radioactive element is 
incorporated into a compound that is familiar to the body, such as glucose, water, 
ammonia, or certain drugs. The radioactive compound is then administered to the 
patient, usually by injection, and a specially designed PET scanner images how the 
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body processes the introduced material. The radiopharmaceuticals discharge 
positrons from wherever they are located in the body. As these positrons encounter 
elements within the body, gamma rays are produced from resulting reactions. 
A patient preparing to undergo a PET scan must first lie on a table that slides into the 
middle of the scanner (see Figure 3.3.1). Inside the scanner are rings of detectors 
constructed with special crystals that produce light when struck by a gamma ray. The 
internal electronics of the scanner record the detected gamma rays and map an 
image of the area where the radiopharmaceutical is located. Because the 
radiopharmaceutical contains a chemical that is regularly used by the body, PET 
enables a physician to see the location of the metabolic process. For example, 
glucose (a sugar which the body uses to produce energy) combined with a 
radioisotope shows where glucose is being utilized in the brain, the heart muscle, or a 
growing tumor (CTI PET Systems Patients' Info). 
Figure 3.3.1. CTI ECAT® Tomograph (PET Scanner) 
In summary, a PET patient receives an intravenous injection of a radioactive tracer. 
The radioactive compound is then distributed throughout the body and processed by 
the organs being studied. The PET scanner records the position of the tracer as the 
emitted positrons interact with electrons in the body (positron annirlilation), creating 
gamma radiation that can be detected by detectors outside the body. A computer 
reconstructs the pattern of detected radioactivity into three-dimensional pictures of the 
body. 
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Figure 3.3.2. PET Image of Upper Body 
3.4 PET Cost Effectiveness 
PET is responsible for improved accuracy in diagnosis, avoidance of unnecessary 
surgeries, and significant savings for surgeries not performed. Gambhir et al report 
that the use of both PET and CT scans provides a savings of $1154 per patient over 
the use of the CT scan alone (1432). 
The ICP Cardiology Task Force contends that the myocardial viability assessment is 
more accurate with PET than with the Thallium stress test. They note that PET is 
capable of screening out patients without viable tissue who would not benefit from 
surgery. Such knowledge has allowed the number of unnecessary catheterizations to 
reduce by 280/0 and the number of unnecessary CABGs (Coronary Artery Bypass 
Grafting) to reduce by 12%. Fewer surgeries ultimately result in a reduction in the 
number of potential post-surgical complications. Lastly, PET is useful in determining 
viable candidates for cardiac transplants (ICP Cardiology Task Force). 
4 eTI PET Systems, Inc. 
CTI is the leading supplier of products and services for the Positron Emission 
Tomography market. CTl's product line includes the RDS cyclotron products, the 
RDS chemical synthesis units, and the ECA ~ tomograph (i.e., PET scanner) 
products. Cyclotrons are particle accelerators that generate positron emitting 
isotopes. The chemical synthesis units incorporate these isotopes into radiolabeled 
compounds which, through injection or inhalation, are taken up in body tissue in 
proportion to biochemical activity. A scanner then detects this radiation emitted from 
positron decays and forms images of the labeled compound distribution. Together 
they work to provide significantly more valuable diagnostic information for physicians 
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compared to conventional anatomical imaging techniques. CTI also provides other 
PET-related products and services, including the distribution of selected PET 
compounds in major metropolitan areas. 
5 Project Outline 
My involvement in CTrs PET innovations was focused mainly on the development of 
a new PET scanner, currently termed the "P39 Project." The electronics and 
programming involved with this project are extremely complicated and require the 
combined efforts of the entire Research and Development department at CTI. I 
contributed to a small portion of this network by focusing on an electronic board 
termed the "Coincidence Point Source Interface" and an EEPROM (Electrically 
Erasable Programmable Read Only Memory) chip termed the "Smart Source". This 
report only includes the results of my research and contributions since most of the 
other components of the P39 Project have yet to be completed. The three major 
areas of my work include the Coincidence Point Source Interface, the Smart Source 
Board, and the Smart Source Test Hardware/Software. 
5.1 PET Transmission Overview for the P39 Project 
In addition to collecting emission data by detecting gamma radiation produced within 
a patient who has received a radiopharmaceutical injection, transmission data must 
also be collected to correct a large source of error in the emission data. This error is 
caused by the attenuation of gamma radiation within the body or entity being 
measured. This means that some gamma radiation will interact with elements within 
the body, and thus, will never reach a detector. The radiation that does not interact 
with a detector is not accounted for unless physicians are able to determine the 
number of gammas that are typically "lost" to interactions within the body. By 
accurately measuring the gamma radiation attenuation, a simple normalization can be 
made to correct the acquired emission data for a given attenuation. 
The P39 transmission source will utilize a transmission system in which a point 
source is loaded with a positron isotope (either 68Ge or 22Na), and ten of these point 
sources will be loaded into a Point Source Assembly (Overbay). When an isotope 
within a point source emits a positron, positron annihilation will occur as soon as the 
positron combines with an atomic electron. As positron annihilation occurs, two 
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0.511-MeV gamma photons are emitted 180 degrees from one another. In order to 
insure that only the annihilation photons are counted, two detectors are placed 180 
degrees apart. A high-speed detector is placed adjacent to the source in order to 
collect one of the gamma photons produced by the positron annihilation. Fast signal 
processing electronics record these detector events and perform coincidence 
measurements. Coincidence measurements include only those events in which the 
two annihilation gammas are detected simultaneously within their respective 
detectors. If the detector that is adjacent to the source detects an annihilation 
gamma, but the second detector does not, the undetected gamma photon has most 
likely been attenuated within the body. 
This system has the ability to acquire emission and transmission data concurrently, 
which permits better registration of emission and transmission data since there is less 
opportunity for a patient's body to shift between the transmission and emission 
acquisitions. 
5.2 Definitions 
Smart Source 
Smart Source Board 
Point Source Assembly 
Coincidence Point Source 
Interface 
Detector Head Interface 
Dallas Semiconductor EEPROM which enables 
the storage of activity and manufacture date for 
each of the ten pOint sources 
Small pc-board to which Smart Source EEPROM 
is mounted 
Assembly containing all components of the point 
source mechanism; includes a rod with ten 
windows, ten pOint sources and photomultiplier 
tubes, sensors, motor, and Smart Source Board 
Interface board between the Smart Source Board 
and the Detector Head Interface; use of several 
connectors 
Board that communicates with the Coincidence 
Point Source Interface and reads the Smart 
Source contents 
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5.3 Acronyms and Abbreviations 
BOM 
CPSI 
CRC 
DHI 
ECAT 
EEPROM 
ESD 
PET 
PMT 
PSA 
SSB 
SS 
UDP 
Bill of Materials 
Coincidence Point Source Interface Board 
Cyclic Redundancy Check 
Detector Head Interface 
Emission Computerized Axial Tomography 
Electrically Erasable Programmable Read Only Memory 
Electrostatic Discharge 
Positron Emission Tomography 
Photomultiplier Tube 
Point Source Assembly 
Smart Source Board 
Solid State (Relays) 
Universal Data Packet 
6 Coincidence Point Source Interface 
This section describes the initial specifications that I wrote for the P39 Project 
Coincidence Point Source Interface board. The Coincidence Point Source Interface 
board (CPSI) provides communication between the detectors, Point Source Assembly 
(PSA) motor and sensors, power supplies, and detector electronics of the P39 PET 
scanner. The CPSI resides adjacent to the PSA. 
6.1 Functionality 
The CPSI provides convenient connection points for power, detectors, signal cables 
to the detector electronics, motor, and motion sensors. It provides high voltage for 
the photomultiplier tubes (PMTs), and the CPS I has preamplifiers for each PMT 
output. Two relays on the CPSI are responsible for switching the 220 VAC to the 
motor on the PSA. When the relay circuits close, current flows to the PSA motor in 
order to drive it forward. As the motor rotates, it extends the PSA point source rod 
outward using a "rack and pinion" drive, until a mechanical stop is reached (each of 
the ten point sources is aligned with its respective window at this point). The outward 
movement of the rod causes a powerful spring, attached to the rod assembly, to 
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stretch and gain tension. Once rod motion ceases, the motor stalls while data is 
being collected since it is still receiving power (the proposed motor can stall 
indefinitely without resulting in damage or burn-up). After all data collection is 
complete, the relay circuits open and terminate current flow to the motor. The spring 
begins to recoil as soon as the motor loses power, and as a result, it drives the motor 
backwards. This reverse drive causes the rod to retract to its original position such 
that the point sources are no longer exposed. The electronics assembly mounts 
within the cover of the PSA mechanical assembly. 
Smart Source .---------------------------~7. EEPROM 1/0 
EEPROM Source Extended 
r-------------------------i' Source Retracted 
Point Source : ~ 
PMT A .----VPreamPlifier 
Point Source : ~ 
PMT B 4-----[/preamPlifier 
Point Source : ~ 
PMT C .----vPreamplifier 
Point Source : ~ 
PMT D 4-----vPreamplifier 
Point Source .------1 
PMT 
Point Source 4------1 
PMT F 
Point Source .------1 
PMTG 
Point Source .------1 
PMTH 
Point Source : ~ 
PMT I 4-----~reamplifjer 
Point Source 4------1 
PMT J 
Laser Module 
Laser Module 
Motor "On" Signal 
+5V 
GND 
-5.2 V 
~+12V 
ToDHI 
Figure 6.1 Block Diagram of Coincidence Point Source Interface Board 
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6.2 Components 
The CPSI contains several electrical components, and the descriptions of the 
preamplifiers and relays are discussed below. 
6.2.1 Preamplifiers 
The PMTs of the PSA have to run at a low gain. This is due to the high count rates 
expected as a result of the detector proximity to the point source. Considering this 
count rate and the overall light output from the detector crystal, low PMT gain is the 
only way to avoid damaging high average anode current in the tube (Moyers). 
Because of the low PMT gain, preamplification is required to boost the signals to 
levels required by the analog processor. The preamplifier circuit will be a simple one-
or two-stage (depending on the gain needed) current feedback operational amplifier 
design. The amplifier gains have yet to be determined. A delay line may be required 
to correct for the short time of flight of the PSA PMTs. Output is differential, reducing 
noise at the analog processor. The block diagram of the preamplifier/delay circuit is 
shown in Figure 6.2. 
PMT 
Input 
6.2.2 Relays 
Output 
Figure 6.2. PMT Preamplifier/Delay Circuit 
Two Solid State (SS) single pole relays will be used on the CPSI to control current 
flow to the PSA motor. Once the relays receive an enabling signal from the Detector 
Head Interface (DHI), the relay circuits will close allowing current to flow to the motor. 
The relays will have an input of 220 VAC. They are paired for redundancy purposes 
if one fails, opening one leg of the motor power will still allow the sources to retract. 
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6.3 Risk Assessment & Hazard Analysis 
A comprehensive Risk Assessment and Hazard Analysis will not be considered at this 
level unless an assembly or subassembly analysis shows that it is warranted. High 
voltage is not present on the board, and no board components are high current. 
Therefore, the risk of fire is minimal on the CPSI. 
6.4 Initial Production, Verification, & Validation 
6.4.1 Initial Production 
Initial Production Units of the CPSI will be built prior to Release to Production of the 
Coincidence Point Source Interface assembly. These units will be assembled by 
Benchmark Electronics. The Responsible Engineer will be accountable for testing the 
units built prior to Release to Production. All documentation pertaining to the 
assurance of these units' functionality will be retained in the Coincidence Point 
Source Interface design notebook. Changes to the initial design will be documented 
in the P39 project notebook. 
6.4.2 Verification 
At least six units will be built first. These units will be visually inspected for 
consistency to the schematics and bill of materials (BOM). All power connections will 
then be checked for shorts with an ohmmeter. The unit will be powered on the 
bench, and desired operation of all circuits will be verified and documented. 
6.4.3 Validation 
Validation of the assembly will be performed through integration with the detector 
panel and the detector electronics. The detectors are assembled and attached to the 
Detector Panel Interface board, which is connected to the detector electronics. 
System setups will be performed, and the performance of the overall 
detector/electronics documented. 
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6.5 Additional Requirements 
6.5.1 Labeling & Packaging Requirements 
All boards will have CTI part numbers, serial numbers, and revision levels clearly 
marked. They will be handled and shipped according to the usual Electrostatic 
Discharge (ESD) precautions. 
6.5.2 Environmental Limitations 
The CPSI will be enclosed in the gantry. which is sealed and environmentally 
controlled. 
6.5.3 Applicable Standards & Regulatory Requirements 
• European Union Medical Device Directive (MDD), 12 July 1993, 93/42/EEC. 
• Quality System Regulation, 21 CFR Part 820 Medical Devices; Current Good 
Manufacturing Practice (CGMP). 
• ANSIIASQC Q9001-1994 (ISO) Quality Systems Model for Quality Assurance in 
Design, Development, Production, Installation, and Servicing. 
• IEC 601-1-4, Medical Electrical Equipment - General Requirements for Safety. 
6.6 Cost Goal 
Each Coincidence Point Source Interface Board will cost approximately $300 to build. 
6.7 Tentative Schedule 
TASK Du ration (days) 
Develop the P39 CPSI Board 25 
Initial Specifications 2 
Design 13 
Schematics 5 
Choose Parts I Create BOM 3 
Design Review 2 
P39 CPSI Board Layout 14 
PCB Placement/Routing 13 
Placement/Routing Review 1 
P39 CPSI Board Verification 10 
Verify six boards 5 
Develop ValidationlT est Procedure 5 
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7 Smart Source Board 
This section describes the initial specifications that I wrote for the P39 Project Smart 
Source Board. The Smart Source Board (SSB) connects to the CPSI to relay source 
strength information to the Detector Head Interface. The SSB stores source strength 
and other general information in an EEPROM, and it connects to the CPSI via a 
flexible cable. 
7.1 Functionality 
The P39 system will employ positron isotopes for radiation sources. These positron-
emitting isotopes suffer from relatively short half-lives of either 0.740 years (for 68Ge) 
or 2.66 years (for 22Na). This diminishing source activity can lead to errors in 
quantification in PET scanning if not accounted for. Thus, it is important that the 
transmission sources be replaced at regular intervals to ensure adequate isotope 
activity to support quality transmission imaging. Present coincidence transmission 
systems lack an automated way to account for source activity each time the sources 
are changed. When new sources are placed in the tomograph, a manual notation 
must be made of the source manufacture date and activity of each source. This 
burden would be significant while trying to maintain the twenty different sources of the 
two P39 point source assemblies. 
In order to determine when the sources decay below a minimum useful activity 
without manual treatment, the P39 PSAs will be assembled with a Dallas 
Semiconductor Smart Source EEPROM. This EEPROM contains enough memory to 
store the measured activity and date of the source manufacture for each of the ten 
point sources within a PSA. Data encryption methods will be applied to the data 
stored in the chip to allow error checking when reading the chip contents. 
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t') C§ 
4 3 
DS2433 
5 6 7 8 
To CPSI 
Figure 7.1. Block Diagram of Smart Source Board 
The SSB will interface with the CPSI. The DHI will then communicate with the CPSI, 
allowing interrogation of the Smart Source EEPROM. Firmware on the DH I will read 
the contents of the EEPROM and make this data available to the Emission 
Computerized Axial Tomography (ECAT) software. This will permit the capability of 
automatic transmission source-strength correction as well as notification of the 
operator when sources are nearing replacement time. The unique serial number in 
each Smart Source chip permits source traceability for regulatory purposes. 
Physically, the Smart Source EEPROM will be mounted on a small pc-board (SSB) 
with a flexible cable terminated by a connector that will plug into a connector on the 
CPSI. Since the head of the SSB moves approximately one-half inch when the 
source extends, a flexible cable is important. 
7.2 Components 
The Smart Source Board contains an EEPROM and a connector. The EEPROM is 
described below. 
7.2.1 Smart Source EEPROM 
The Dallas Semiconductor Smart Source EEPROM is a self-contained electronic chip 
that has a permanent unique serial number as well as 4k-bits of non-volatile memory. 
The chip will be programmed by a PC interface at the time of source manufacture. 
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Each Smart Source chip is loaded with the measured activity and date of source 
manufacture for each of the ten point sources in the P39 point source assembly. An 
8-pin, 4-kbit EEPROM (OS2433) will be used in this application. The EEPROM will 
be programmed using a OS9097U-S09 serial port adapter and a modified OS14020-
OR8 blue dot receptor. The programming connector from the computer can be the 
same type of connector used to connect the pc-board to the CPSI (OS2433 4k-Bit 1-
Wire™ EEPROM Data Sheet). 
7.3 Risk Assessment & Hazard Analysis 
A comprehensive Risk Assessment and Hazard Analysis will not be considered at this 
level unless an assembly or subassembly analysis shows that it is warranted. High 
voltage is not present on the board, and the OS2433 EEPROM is a low current 
component. Therefore, there is essentially no risk associated with the SSB. 
7.4 Initial Production, Verification, & Validation 
7.4.1 Initial Production 
Initial Production Units of the SSB will be built prior to Release to Production. These 
units will be assembled by Benchmark Electronics. The Responsible Engineer will be 
accountable for testing the units built prior to Release to Production. All 
documentation pertaining to assurance of these units' functionality will be retained in 
the Smart Source design notebook. Changes to the initial design will be documented 
in the P39 project notebook. 
7.4.2 Verification 
At least six units will be built first. These units will be visually inspected for 
consistency to the schematics and BOM. All power connections will then be checked 
for shorts with an ohmmeter. The unit will be powered on the bench, and desired 
operation of all circuits will be verified and documented. 
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7.4.3 Validation 
The Smart Source board will be connected to a host processor such that correct read 
and write operations may be verified by someone other than the responsible 
engineer. Any problems encountered will be fixed before release. 
7.5 Additional Requirements 
7.5.1 Labeling & Packaging Requirements 
All boards will have CTI part numbers, serial numbers, and revision levels clearly 
marked. They will be handled and shipped according to the usual ESD precautions. 
7.5.2 Environmental Limitations 
The SSB will be enclosed in the gantry, which is sealed and environmentally 
controlled. 
7.5.3 Applicable Standards & Regulatory Requirements 
• European Union Medical Device Directive (MOD), 12 July 1993, 93/42/EEC. 
• Quality System Regulation, 21 CFR Part 820 Medical Devices; Current Good 
Manufacturing Practice (CGMP). 
• ANSI/ASQC Q9001-1994 (ISO) Quality Systems Model for Quality Assurance in 
Design, Development, Production, Installation, and Servicing. 
• IEC 601-1-4, Medical Electrical Equipment - General Requirements for Safety. 
7.6 Cost Goal 
Each Smart Source Board will cost approximately $50 to construct. 
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7.7 Schedule 
• TASK Duration (days) 
Develop the P39 Smart Source Board 17 
Initial Specifications 2 
Design 5 
Schematics 4 
I Choose Parts/ Create BOM 4 
Design Review 1 
Verify Components/ Netlist 1 
P39 Smart Source Board Layout 3 
PCB PlacemenU Routing 2 
PlacemenURouting Review 1 
P39 Smart Source Board Verification 7 
Verify two or three boards 2 
Develop Validation/ Test Procedure 5 
Develop the Windows programming software 22 
Find/Design an Encryption/ Decryption Algorithm 5 
Create GUI Framework 2 
Add Programming functionality 10 
TesU Debug 5 
Develop DHI Firmware to Support the Smart Source Board 20 
8 Smart Source Testware 
This section describes the P39 Smart Source test hardware and software, which are 
used to store the source information in the Smart Source EEPROM. I developed the 
Smart Source dialog interface software, which can be used with associated hardware 
to quickly write an EEPROM and test it for proper operation. 
8.1 Need for Product 
PET scan operators must be able to determine when sources decay below a 
minimum useful activity. Therefore, the P39 PSA will be assembled with a Dallas 
Semiconductor Smart Source EEPROM mounted to the SSB. While the EEPROM 
contains sufficient memory to store activities and manufacture dates, both software 
and hardware are needed to write the necessary information to the EEPROM. The 
Smart Source information results in the capability of automatic transmission source-
strength correction as well as notification of the operator when sources are nearing 
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replacement time. Ultimately, this interface allows a user to quickly write to an 
EEPROM and to test whether or not the EEPROM is working properly. 
8.2 Structure & Interfaces 
As sources are generated in the laboratory, a software interface is needed to allow 
technicians to enter the appropriate source data into the EEPROM. This user 
interface utilizes dialog boxes for simplicity and was constructed in Visual C++. An 
example of the dialog interface is shown in Figure 8.2. 
:f:t Record of P39 Point Source Date and Strength EJ 
Date I 8/10/01 3 Source Strength #1 (mCi) 11.23 
Isotope IGE68 3 Source Strength #2 (mCi) 12.34 
Source Strength #3 (mCi) J3.45 Isotope Source IDOE 3 
Complete I 
3 Source Strength #4 (mCi) 14.56 M anuf acturer JCTI 
Source Strength #5 (mCi) J5.67 E><it 
Assembly Serial No. IABC789 
JCINDY 
Source Strength #6 (mCi) J6.78 
Technician's First Name 
17.89 Source Strength #7 (mCij 
Technician's Last Name JJONES Source Strength #8 (mCi) 18.90 
Source Strength #9 (mCi) 19.01 
[ 5t~us Source Strength #10 (mCi) 110.00 
II I ~ 2 3 4 5 6 7 8 9 10 
Done. 
-
• • • • • • • - I 
Figure 8.2. User Dialog Interface 
Also, if there are problems during or prior to writing, specific error messages appear 
to help the user correct the problem. Once the user has entered valid information, the 
interface encrypts the date and activity source data, and then writes the data to the 
EEPROM with other general information. This information is then read back, in 
decrypted form, and verified before completion. 
8.3 Hardware & Software 
This section contains descriptions of the hardware and software components 
associated with the Smart Source. 
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8.3.1 Pentium PC with Windows 95,98, or 2000 
This component is used both in the development of the interface software and in the 
actual application of the interface software. The sources lab technician needs the PC 
to execute the interface dialog software for writing to the EEPROM. 
8.3.2 Microsoft Visual C++ 
Visual C++ and the Dallas Semiconductor Software Developer's Kit were used to 
develop the code to read and write the Smart Source EEPROM. The C++ code 
provides the means to encrypt and download the desired source data into the 
EEPROM and to test whether or not the EEPROM is working properly. Firmware on 
the DHI utilizes the same decryption algorithm to correctly decode the data. The 
encryption/decryption code is used to encrypt and decrypt the data to be stored in the 
EEPROM. This algorithm employs a key, which will be unique for each device by 
using certain combinations of the EEPROM serial number. The method of key 
generation is a secret among CTI's Research and Development engineers and is not 
needed by the user (Jones). (Due to a CTI confidentiality contract, further details 
cannot be provided about the encryption code I wrote for Smart Source applications.) 
8.3.3 DS2433 EEPROM 
The Dallas Semiconductor Smart Source EEPROM is a self-contained electronic chip 
that has a permanent unique serial number as well as 4k-bits of non-volatile memory. 
The chip is programmed by a PC interface at the time of source manufacture. Each 
Smart Source chip is loaded with the measured activity and date of source 
manufacture for the ten point sources of the P39 PSA. 
8.3.4 DS9097U-S09 Universal Serial Port Adapter 
This adapter connects to the PC serial port and to a blue dot receptor. The adapter 
enables a PC to directly read and write the 1-wire EEPROM (DS9097U-S09 Universal 
Serial Port Adapter Data Sheet). 
8.3.5 DS1402D-DR8 Blue Dot Receptor 
This device contains an 8-foot coiled cable with two blue dot receptors on one end to 
provide touch communication with an iButton™ EEPROM. The other end has a 
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RJ-11 connector to connect to the serial port adapter. Since this receptor is 
manufactured to support iButtonsTM, it will have to be slightly modified to provide 
interface for non-metal can packaged EEPROMs. This modification will be 
documented so that it can be reproduced (OS14020-0R8 Blue Dot Receptor Data 
Sheet). 
8.4 Overview of EEPROM Storage 
8.4.1 64-Bit Lasered ROM 
Each OS2433 contains a unique ROM sequence that is 64 bits long. The first eight 
bits are a 1-Wire family code, and the next 48 bits are a unique serial number. The 
last eight bits are a Cyclic Redundancy Check (CRC) of the first 56 bits. The 1-Wire 
CRC is generated using a polynomial generator conSisting of a shift register and 
exclusive OR gates, modeled by the polynomial X8+X5+X4+1. The shift register bits 
are initialized to zero. Then, starting with the least significant bit of the family code, 
one bit at a time is shifted in. After the 8th bit of the family code has been entered, 
then the serial number is entered. After the 48th bit of the serial number has been 
entered, the shift register contains the 8-bit CRC value. This CRC value is verified by 
an independent C++ calculation before writing to the EEPROM (Application Note 27 -
Understanding and Using Cyclic Redundancy Checks). 
8.4.2 EEPROM Memory Map 
The EEPROM contains a 32-byte page called the scratchpad and sixteen additional 
32-byte pages called memory. The OS2433 contains pages 0 through 15, which 
compose the 4096-bit EEPROM memory. The scratch pad is an additional page that 
acts as a buffer when writing to memory. For this application, only pages 0-6 store 
data. 
8.4.3 Universal Data Packet 
The Universal Data Packet (UOP) is a structure used to store data on the EEPROM. 
It includes 1-2 bytes representing the string length of the data it contains, followed by 
the data string, and then two inverted CRC bytes. This CRC value is 16 bits, rather 
than 8, and it is generated according to the standardized polynomial function 
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X 16+X 15+X2+1. In contrast to the 8-bit CRC, the 16-bit CRC is always returned or sent 
in inverted form. 
UOPs always start on page boundaries but can end anywhere. The first 1-2 bytes 
representing string length contain the number of data bytes excluding the length 
byte(s) and the CRC16 bytes. There is only one length byte when the number of data 
bytes is less than 255 (always the case in this application). If there are 255 or more 
data bytes, then the first length byte is 255 and the next length byte is 0 to 253. The 
first and second length bytes added together provide the total number of data bytes. 
The CRC16 is first initialized to the starting page number in order to verify that the 
correct page is being read. The CRC16 is then calculated over the length and data 
bytes. It is then inverted and stored low byte first followed by the high byte (OS2433 
4k-Bit 1-Wire™ EEPROM Data Sheet). 
8.4.4 Location of data in the EEPROM 
** Specific encryption data has been omitted to protect confidentiality agreement with CTI. ** 
Page 0 
Byte 0 I Length of Identification String (including null character) = 21 
Bytes 1-20 Identification String = CTI PET Systems Inc . 
. Byte 21 Null Character = 0 
Bytes 22-23 16-bit CRC Value = 6, 64 
I Bytes 24-31 Empty 
Page 1 
i Byte 0 Length of Serial Number String (including null character) = x 
Bytes 1-(x-1) Serial Number String 
Byte x Null Character = 0 
Bytes (x+1) - (x+2) 16-bit CRC Value 
Bytes (x+3) - 31 Empty 
Page 2 
Byte 0 Length of First Encrypted Source String (including null character) 
Bytes 1-8 Encrypted Data Set #1 
Byte 9 Encrypted Character Divider 
Bytes 10-14 Encrypted Data Set #2 
Byte 15 Encrypted Character Divider 
Bytes 16-20 Encrypted Data Set #3 
Byte 21 Encrypted Character Divider 
Bytes 22-26 Encrypted Data Set #4 
Byte 27 Null Character = 0 
Bytes 28-29 16-bit CRC Value 
Bytes 30-31 Empty 
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Page 3 
Byte 0 Length of Second Encrypted Source String (including null character) 
iytes 1-5 Encrypted Data Set #5 
yte6 Encrypted Character Divider 
Bytes 7-11 Encrypted Data Set #6 
Byte 12 Encrypted Character Divider 
Bytes 13-17 Encrypted Data Set #7 
Byte 18 Encrypted Character Divider 
Bytes 19-23 Encrypted Data Set #8 
Byte 24 Null Character 0 
Bytes 25-26 16-bit CRC Value 
Bytes 27-31 Empty 
Page 4 
Byte 0 ~ of Third Encrypted Source String (including null character) 
Bytes 1-5 pted Data Set #9 
Byte 6 Encrypted Character Divider 
Bytes 7-11 Encrypted Data Set #10 
Byte 12 Encrypted Character Divider 
Bytes 13-17 Encrypted Data Set #11 
I Byte 18 Encrypted Character Divider 
; Bytes 19-21 Encrypted Data Set #12 
I Byte 22 Encrypted Character Divider 
Bytes 23-26 Encrypted Data Set #13 
I Byte 27 Null Character = 0 
Bytes 28-29 16-bit CRC Value 
Bytes 30-31 Empty 
Page 5 
Byte 0 Length of Combination Isotope String (including null character) = 21 
Bytes 1-5 Isotope (stored as 5 bytes; empty bytes appear as space char.) 
Byte 6 Space Character 
Bytes 7-16 Isotope Source (stored as 10 bytes; empty bytes appear as space char.) 
Byte 17 Space Character 
Bytes 18-20 Manufacturer (stored as 3 bytes; empty bytes appear as space char.) 
I Byte 21 Null Character = 0 
I Bytes 22-23 16-bit CRC Value 
Bytes 24-31 Empty 
Page 6 
Byte 0 Length of Entire Encrypted Name String (including null character) = x 
Bytes 1 - Y Encrypted Data Set #14 (length = y) 
Byte (y+1) Encrypted Character Divider 
Bytes (y+2) - (x-1) Encrypted Data Set #15 
Byte x Null Character = 0 
Bytes (x+1) - (x+2) 16-bit CRC Value 
Bytes (x+3) - 31 Empty 
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8.5 Version Control & Validation 
8.5.1 Version Control 
Version control of this software is handled by PVCS version control software by 
Merant. The PVCS currently in use is version 6.7. The first working version of the 
software was stored using PVCS. Any modifications will be shown in the description 
of the new PVCS version. 
8.5.2 Validation 
The Smart Source EEPROM will be connected to a host processor such that correct 
read and write operations may be verified by someone other than the responsible 
engineer. Any problems encountered will be fixed before release. 
8.6 Schedule 
TASK Duration (days) 
Develop the Windows programming software 22 
Find/Design an Encryptionl Decryption Algorithm 5 
Create GUI Framework 2 
Add Programming functionality 10 
Test! Debug 5 
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9 Conclusion & Recommendations 
My greatest learning experience and most significant contribution to CTI's P39 
Project was the Smart Source Testware development. This task required me to write 
programs in Microsoft Visual C++, a language I had never used prior to this project. 
also learned to read and write EEPROMs for the first time. 
My C++ programming efforts enabled CTI technicians to enter source data 
into a dialog interface (shown in Figure 8.2). The technician then clicks the 
"Complete" button, and the program proceeds to check for errors in the submitted 
data, improper connections between the PC and EEPROM, and failures of the 
EEPROM itself. If problems do arise prior to or during writing, specific error 
messages appear to help the user correct the problem. When no errors are present, 
the program encrypts the source and technician identification data, and then writes 
the data to the EEPROM along with other necessary information. This information is 
then decrypted and verified before completion. The technician is notified when 
writing is complete and successful. 
The Smart Source Testware can be used for other applications in CTI PET 
scanners as well. My code is well documented and can easily be modified for use in 
new assignments with similar requirements. Currently, the encryption/decryption 
portion of the code is of particular relevance and value to other CTI products. 
My experiences with CTI were exciting and beneficial to my education in 
nuclear engineering. Furthermore, the CTI employees were friendly and willing to 
share their expertise. I gained practical knowledge during this internship that far 
surpassed any of my experiences during previous jobs or university courses. I would 
definitely recommend that future engineering students take advantage of an 
opportunity to work with CTI and its innovative PET technology. 
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